Hikma Pharmaceutic (HKMPF) Rating Lowered to Reduce at HSBC Holdings plc

Hikma Pharmaceutic (OTC:HKMPF) was downgraded by research analysts at HSBC Holdings plc from a “hold” rating to a “reduce” rating in a research note issued to investors on Friday, StockTargetPrices.com reports.

Hikma Pharmaceutic (OTC:HKMPF) opened at 26.50 on Friday. Hikma Pharmaceutic has a 52-week low of $20.43 and a 52-week high of $35.25. The firm’s 50-day moving average price is $25.26 and its 200 day moving average price is $24.41. The firm has a market cap of $5.99 billion and a PE ratio of 32.40.

var userip;Your IP Address: document.write(userip);

Stock Target Prices

Receive News & Ratings for Hikma Pharmaceutic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceutic and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Teen Girls Barred from United Airlines Flight for Wearing Leggings
Teen Girls Barred from United Airlines Flight for Wearing Leggings
Fuel Shortage in Venezuela Growing Worse
Fuel Shortage in Venezuela Growing Worse
FedEx Comes Up Short on Earnings
FedEx Comes Up Short on Earnings
Brazil Looks to Calm Fears Over Export and Sale of Meat
Brazil Looks to Calm Fears Over Export and Sale of Meat
Dollar General Increasing Pay, Lowering Price and Adding Perishable Goods
Dollar General Increasing Pay, Lowering Price and Adding Perishable Goods
Euronet Worldwide Tops Offer by Ant to Acquire MoneyGram
Euronet Worldwide Tops Offer by Ant to Acquire MoneyGram


Leave a Reply

© 2006-2017 Ticker Report. Google+.